Reichel, Fabian https://orcid.org/0009-0007-7905-1060
Tesch, Falko https://orcid.org/0000-0001-8933-643X
Berger, Saskia https://orcid.org/0000-0002-6806-3257
Seifert, Martin
Koschel, Dirk https://orcid.org/0000-0002-5609-4574
Schmitt, Jochen https://orcid.org/0000-0003-0264-0960
Kolditz, Martin https://orcid.org/0000-0001-6022-6827
Funding for this research was provided by:
Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden
Article History
Received: 18 April 2024
Accepted: 30 May 2024
First Online: 27 June 2024
Declarations
:
: Data of this study was retrieved from statutory health insurance AOK PLUS and was originally recorded for accounting purposes. The analysis was approved by the Saxon State Ministry for Social Affairs and the ethics committee of TU Dresden (EK 143052018).
: DK reports payment or honoraria for lectures from AstraZeneca, Berlin-Chemie, Boehringer Ingelheim, Chiesi, GSK, Novartis, Pfizer, Roche and Sanofi as well as participation in advisory boards for AstraZeneca, Boehringer Ingelheim, GSK and Sanofi; all outside of the submitted work.JS reports institutional grants for investigator-initiated research from the German Federal Joint Committee, German Ministry of Health, German Ministry of Research, European Union, German Federal State of Saxony, Novartis, Sanofi, ALK and Pfizer. He participated in advisory board meetings as a paid consultant for Sanofi, Lilly and ALK. JS serves the German Ministry of Health as a member of the German National Council for Health and Care.MK reports research grants from Pfizer, payment or honoraria for lectures from AstraZeneca, Berlin-Chemie, Boehringer Ingelheim, Gilead, GSK, Insmed, Pfizer and participation in advisory boards for AstraZeneca, Sanofi, GSK, Insmed; all outside of the submitted work.All other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.